Heart failure in the fetus

Pediatric Heart Failure

Volumn , Issue , 2005, Pages 171-207

  Hornberger, Lisa K ^a   Nii, Masaki ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953415066     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (92)

1. Rudolph AM. Distribution and regulation of blood flow in the fetal and neonatal lamb. Circ Res 1985; 57:811-821.
2. Kenny JF, Plappert T, Doubilet P, Saltzman DH, Cartier M, Zollars L, Leatherman GF. St John Sutton MG Changes in intracardiac blood flow velocities and right and left ventricular stroke volumes with gestational age in the normal human fetus: a prospective Doppler echocardiographic study. Circulation 1986; 74:1208-1216.
3. Fishman NH, Hof RB, Rudolph, et al. Models of congenital heart disease in fetal lambs. Circulation 1978; 58:354-364.
4. Rudolph AM, Heyman MA. Cardiac out in the fetal lamb: the effects of spontaneous and induced changes of heart rate on right and left ventricular output. Am J Obstetr Gynecol 1976; 124:183-192.
5. Reuss ML, Rudolph AM, Dae MW. Phasic blood flow patterns in the superior and inferior venae cavae of fetal sheep. Am J Obstetr Gynecol 1983; 143:70-78.
6. Kanzaki T, Chiba Y. Evaluation of the preload condition of the fetus by inferior vena caval blood flow pattern. Fetal Diagn Ther 1990; 5: 168-174.
7. Johnson P, Sharland G, Allan LD, Tynan MJ, Maxwell DJ. Umbilical venous pressure in non-immune hydrops fetalis: correlation with cardiac size. Am J Obstetr Gynecol 1992; 167:1309-1313.
8. Brace RA. Effects of outflow pressure on fetal lymph flow. Am J Obstetr Gynecol 1989; 160:494-497.
9. Brace RA, Valenzuela GJ. Effects of outflow pressure and vascular volume loading on thoracic duct lymph flow in adult sheep. Am J Physiol 1990; 258:R240-R244.
10. Rudolph AM. The Fetal Circulation and Postnatal Adaptation. Congenital Disease of the Heart: Clinical-Physiological Considerations. Chapter 1. Armonk, NY: Futura Publishing Co., 2001:38-43.
11. Jaeggi ET, Fouron J-C, Hornberger LK, Proulx F, Iberhaensli-Weiss I, Fermont L. Agenesis of the ductus venosus associated with extrahepatic umbilical vein drainage: clinical presentation, echocardiographic features and fetal outcome. Am J Obstetr Gynecol 2002; 187: 1031-1037.
12. Fontes-Pedra SRF, Smallhorn J, Ryan G, Chitayat D, Morghani H, Khan R, Hornberger LK. Fetal cardiomyopathies: etiologies, hemodynamic findings and clinical outcome. Circulation 2002; 106:585-591.
13. Turkel SB. Conditions associated with nonimmune hydrops fetalis. Clin Perinatol 1982; 9(3):613-625.
14. Allan LD, Crawford DC, Sheridan R, Chapman MG. Aetiology of non-immune hydrops: the value of echocardiography. Br J Obstetr Gynaecol 1986; 93:223-225.
15. Machin GA. Hydrops revisited: literature review of 1414 cases published in the 1980s. Am J Med Genet 1989; 34:366-390.
16. Jauniaux E. Diagnosis and management of early non-immune hydrops fetalis. Prenatal Diagn 1997; 17:1261-1268.
17. Respondek M, Respondek A, Huhta JC, Wilczynski J. 2D echocardiographic assessment of the fetal heart size in the 2nd and 3rd trimester of uncomplicated pregnancy. Eur J Obstetr Gynaecol Reprod Biol 1992; 44:185-188.
18. Allan L. The normal fetal heart. Allan L, Hornberger L, Sharland G, eds. Textbook of Fetal Cardiology. Chapter 5. London, UK: Greenwich Medical Media, 2000:95-97.
19. Reed KL, Meijboom EJ, Sahn DJ, Scagnelli SA, Valdes-Cruz LM, Shenker L. Cardiac Doppler flow velocities in human fetuses. Circulation 1986; 73:41-46.
20. Reed KL, Sahn DJ, Scagnelli S, Anderson CF, Shenker L. Doppler echocardiographic studies of diastolic function in the human fetal heart: changes during gestation. J Am Coll Cardiol 1986; 8:391-395.
21. Carcellar-Blanchard AM, Fouron JC. Determinants of Doppler velocity profile through the mitral valve of the human fetus. Br Heart J 1993; 70:457-460.
22. Reed KL, Appleton CP, Anderson CF, Shenker L, Sahn DJ. Doppler of vena cava flows in human fetuses. Circulation 1990; 81:498-505.
23. Okamura K, Murotsuki J, Kobayashi M, et al. Umbilical venous pressure and Doppler flow pattern of inferior vena cava in the fetus. Fetal Diagn Ther 1990; 5:168-174.
24. Huisman TWA, Stewart PA, Wladimiroff JW. Flow velocity waveforms in the fetal inferior vena cava during the second half of normal pregnancy. Ultrasound Med Biol 1991; 17:679-682.
25. Gudmundsson S, Huhta JC, Wood DC, Tulzer G, Cohen AW, Weiner S. Venous Doppler ultrasonography in the fetus with non-immune hydrops. Am J Obstetr Gynecol 1991; 164:33-37.
26. Hecher K, Campbell S, Doyle P, Harrington K, Nicolaides K. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Circulation 1995; 918:129-138.
27. Tulzer G, Gudmundsson S, Wood DC, Cohen AW, Weiner S, Huhta JC. Doppler in non-immune hydrops fetalis. Ultrasound Obstetr Gynecol 1994; 4:279-283.
28. Kleinman CS, Connerstein RL, DeVore GR, Jaffe CC, Lynch KC, Berkowitz RL, Talner NS, Hobbins JC. Fetal Echocardiography for evaluation of in utero congestive heart failure: a technique for study of nonimmune fetal hydrops. N Engl J Med 1982; 306:568-575.
29. Tsang W, van der Velde Mary, Windrim R, Smallhorn JF, Hornberger LK. Hydrops fetalis: primary cardiovascular etiologies and clinical outcome in 98 affected pregnancies. American College of Cardiology Scientific Session, Atlanta, GA. J Am Coll Cardiol 2002; 39(suppl A): 415A.
30. Hornberger LK, Sander SP, Rein AJJT, Spevak JP, Parness IA, Colan SD. Left heart obstructive lesions and left ventricular growth in the midtrimester fetus. A longitudinal study. Circulation 1995; 92: 1531-1538.
31. Hornberger LK, Need L, Benacerraf BR. Hornberger LK, Need L, Benacerraf BR. Development of significant left and right ventricular hypolasia in the second and third trimester fetus. J Ultrasound Med 1996; 15:655-659.
32. Hornberger LK, Sahn DJ, Kleinman CS, Copel JA, Reed KL. Tricuspid valve disease with significant tricuspid insufficiency in the fetus: Diagnosis and outcome. J Am Coll Cardiol 1991; 17(1):167-173.
33. Sharland G, Chita SK, Allan LD. Tricuspid valve dysplasia or displacement in intrauterine life. J Am Coll Cardiol 1991; 17:944-949.
34. Inamura N, Taketazu M, Smallhorn JF, Hornberger LK. Left ventricular myocardial performance in the fetus with severe tricuspid valve disease and tricuspid insufficiency. J Am Coll Cardiol 2002; 39:414A.
35. Pavlova M, Fouron JC, Drblik PD, van Doesburg NH, Bigras JL, Smallhorn J, Harder J, Robertson M. Factors affecting the prognosis of Ebstein’s anomaly during fetal life. Am Heart J 1998; 135: 1081-1085.
36. Silverman NH, Kleinman CS, Rudolph AM, Copel JA, Weinstein AM, Enderlein MA, Golbus M. Fetal atrioventricular valve insufficiency associated with nonimmune hydrops: a two-dimensional echocardiographic and pulsed Doppler ultrasound study. Circulation 1985; 72(4):825-832.
37. Iskaros J, Jauniaux E, Rodeck C. Outcome of nonimmune hydrops fetalis diagnosed during the first half of pregnancy. Obstetr Gynecol 1997; 90(3):321-325.
38. Landrum BG, Johnson DE, Ferrara B, Boros SJ, Thompson TR. Hydrops fetalis and chromosomal trisomies. Am J Obstetr Gynecol 1986; 154:1114-1115.
39. Saller DN, Canick JA, Schwartz S, Blitzer MG, Moerman P, Vandenberghe K, Devlieger H, Van Hole C, Fryns JP, Lauweryns JM. Congenital pulmonary lymphangiectasis with chylothorax: a heterogeneous lymphatic vessel abnormality. Am J Med Genet 1993; 47(1):54-58.
40. Kleinman CS. Prenatal diagnosis and management of intrauterine arrhythmias. Fetal Ther 1986; 1:92-95.
41. Van Engelen AD, Weijtens O, Brenner JI, et al. Management, outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994; 24: 1371-1375.
42. Jaeggi E, Fouron JC, Drblik SP. Fetal atrial flutter: diagnosis, clinical features, treatment, and outcome. J Pediatr 1998; 132:335-339.
43. Simpson JM, Sharland GK. Fetal tachycardias: management and outcome of 127 consecutive cases. Heart 1998; 79:576-581.
44. Jaeggi E, Fouron JC, Fournier A, van Doesburg NH, Drblik SP, Proulx F. Ventriculo-atrial time interval measured on M-mode echocardiography: a determining element in the diagnosis, treatment and prognosis of fetal supraventricular tachycardia. Heart 1998; 79:582-587.
45. Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U. Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 2003; 89:913-917.
46. Naheed ZJ, Strasburger JF, Deal BJ, Benson DW Jr, Gidding SS. Fetal tachycardia: mechanisms and predictors of hydrops fetalis. J Am Coll Cardiol 1996; 27:1736-1740.
47. Chang IK, Shyu MK, Lee CN, Kau ML, Ko YH, Chow SN, Hsieh FJ. Prenatal diagnosis and treatment of fetal long QT syndrome: a case report. Prenat Diagn 2002; 22(13):1209-1212.
48. Lopez LM, Cha SC, Scanavacca MI, Tuma-Cali VM, Zugaib M. Fetal idiopathic ventricular tachycardia with nonimmune hydrops: benign course. Pediatr Cardiol 1996; 17:192-193.
49. SchmidtKG, Ulmer HE, SilvermanNH, Kleinman CS, Copel JA. Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991; 17:1360-1366.
50. Koyanagi T, Hara K, Satoh S, Yoshizato T, Nakano H. Relationship between heart rate and rhythm, and cardiac performance assessed in the human fetus in utero. Int J Cardiol 1990; 28(2):163-171.
51. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block. A single institution’s experience of 30 years. J Am Coll Cardiol 2002; 39:130-137.
52. Nield LE, Silverman ED, Taylor GP, Smallhorn JF, Mullen JB, Silverman NH, Finley JP, Law YM, Human DG, Seaward PG, Hamilton RM, Hornberger LK. Maternal anti-Ro and anti-La antibody associated endocardial fibroelastosis. Circulation 2002; 105:843-848.
53. Barrea C, Ryan G, McCrindle BW, Smallhorn JF, Hornberger LK. Prenatal cardiovascular manifestations in the recipient twin of pregnancies complicated by twin-to-twin transfusion syndrome and the impact of therapeutic amnio reduction. Circulation 2001; 104:II-517.
54. Dickinson JE, Evans SF. Obstetric and perinatal outcomes from the Australian and New Zealand twin-twin transfusion syndrome registry. Am J Obstetr Gynecol 2000; 182:706-712.
55. Mari G, Detti L, Oz U, Abuhamad AZ. Long-term outcome in twin-twin transfusion syndrome treated with serial aggressive amnioreduction. Am J Obstetr Gynecol 2000; 183:211-217.
56. Bajoria R, Sullivan M, Fisk NM. Endothelin concentrations in monochorionic twins with severe twin-twin transfusion syndrome. Human Reprod 1999; 14:1614-1618.
57. Bajoria R, Ward S, Chatterjee R. Natriuretic peptides in the pathogenesis of cardiac dysfunction in the recipient fetus of twin-twin transfusion syndrome. Am J Obstetr Gynecol 2002; 186:121-127.
58. Porepa L, Barrea C, Singhroy S, Hornberger LK. Cellular insights into the role of Endothelin-1 in the cardiovascular pathology of twin-twin transfusion syndrome. J Am Coll Cardiol 2002; 39(suppl 5):415A.
59. Mahieu-Caputo D, Muller F, Joly D, Gubler MC, Lebidois J, Fermont L, et al. Pathogenesis of twin-twin transfusion syndrome: the renin-angiotensin system hypothesis. Fetal Diagn Ther 2001; 16:241-24.
60. Rodriguez MM, Chaves F, Romaguera RL, Ferrer PL, de la Guardia C, Bruce JH. Value of autopsy in nonimmune hydrops fetalis: series of 51 stillborn fetuses. Pediatr Dev Pathol 2002; 5(4):365-374.
61. Henrich W, Fuchs I, Buhrer C, van Landeghem FK, Albig M, Stoever B, Dudenhausen JW. Isolated cardiomegaly in the second trimester as an early sign of fetal hydrops due to intracranial arteriovenous malformation. J Clin Ultrasound 2003; 31(8):445-449.
62. Tonkin IL, Setzer ES, Ermocilla R. Placental chorioangioma: a rare cause of congestive heart failure and hydrops fetalis in the newborn. AJR Am J Roentgenol 1980; 134(1):181-183.
63. Walton JM, Rubin SZ, Soucy P, Benzie R, Ash K, Nimrod C. Fetal tumors associated with hydrops: the role of the pediatric surgeon. J Pediatr Surg 1993; 28(9):1151-1153.
64. Silverman NH, Schmidt KG. Ventricular volume overload in the human fetus: observations from fetal echocardiography. J Am Soc Echocardiogr 1990; 3(1):20-29.
65. Osborn P, Gross TL, Shah JJ, Ma L. Prenatal diagnosis of fetal heart failure in twin reversed arterial perfusion syndrome. Prenatal Diagn 2000; 20(8):615-617.
66. Brassard M, Fouron JC, Leduc L, Grignon A, Proulx F. Prognostic markers in twin pregnancies with an acardiac fetus. Obstetr Gynecol 1999; 94(3):409-414.
67. Mahle WT, Rychik J, Tian ZY, Cohen MS, Howell LJ, Crombleholme TM, Flake AW, Adzick NSE. Echocardiographic evaluation of the fetus with congenital cystic adenomatoid malformation. Ultrasound Obstetr Gynecol 2000; 16:620-624.
68. Riskin-Mashiah S, Moise KJ, Wilkins I, Ayres NA, Fraser CD. In utero diagnosis of intrapericardial teratoma: a case for in utero open fetal surgery. Prenatal Diagn 1998; 18(12):1328-1330.
69. Weber AM, Philipson EH. Fetal pleural effusion: a review and metaanalysis for prognostic indicators. Obstetr Gynecol 1992; 79(2): 281-286.
70. Jaeggi, ET, Fouron J-C, Smallhorn J, Proulx F, Hornberger LK. Prenatally diagnosed complete atrioventricular block with and without structural heart disease in the 1990s-management and impact on outcome. J Am Coll Cardiol 2003; 41:482A.
71. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block. Arth Rheum 1999; 42:2335-2345.
72. Groves AMM, Allan LD, Rosenthal E. Therapeutic trial of sympathomimetics in three cases of complete heart block in the fetus. Circulation 1995; 92:3394-3396.
73. Räsänen J. The effects of ritodrine infusion on fetal myocardial function and fetal hemodynamics. Acta Obstetr Gynecol Scand 1990; 69:487-492.
74. Harris JP, Alexson CG, Manning JA, Thompson HO. Medical therapy for the hydropic fetus with congenital complete atrioventricular block. Am J Perinatol 1993; 10:217-219.
75. Zosmer N, Bajoria R, Weiner E, Rigby M, Vaughan J, Fisk NM. Clinical and echographic features of in utero cardiac dysfunction in the recipient twin in twin-twin transfusion syndrome. Br Heart J 1994; 72:74-79.
76. Anandakumar C, Biswas A, Chew SS, Chia D, Wong YC, Rantam SS. Direct fetal therapy for hydrops secondary to congenital atrioventricular heart block. Obstetr Gynecol 1996; 87: 835-837.
77. Chavkin Y, Kupfersztain C, Ergaz Z, Guedj P, Finkel AR, Stark M. Successful outcome of idiopathic nonimmune hydrops treated by maternal digoxin. Gynecol Obstetr Invest 1996; 42:137-139.
78. Koike T, Minakami H, Shiraishi H, Ogawa S, Matsubara S, Honma Y, Sato I. Digitalization of the mother in treating hydrops fetalis in monochorionic twin with Ebstein’s anomaly. Case report. J Perinat Med 1997; 25:295-297.
79. Hsieh YY, Lee CC, Chang CC, Tsai HD, Yeh LS, Tsai CH. Successful prenatal digoxin therapy for Ebstein’s anomaly with hydrops fetalis. A case report. J Reprod Med 1998; 43(8):710-712.
80. Harlass FE, Duff P, Brady K, Read J. Hydrops fetalis and premature closure of the ductus arteriosus: a review. Obstetr Gynecol Surv 1989; 44:541-543.
81. Wald R, Adatia I, Van Arsdell G, Hornberger LK. J Am Coll Cardiol 2004.
82. Hinrose S, Farmer DL. Fetal surgery for sacrococcygeal teratoma. Clin Perinatol 2003; 30:493-506.
83. Paek BW, Jennings RW, Harrison MR, Filly RA, Tacy TA, Farmer DI, Albanese CT. Radiofrequency ablation of human fetal sacrococcygeal teratoma. Am J Obstetr Gynecol 2001; 184:503-507.
84. Adzick NS, Kitano Y. Fetal surgery for lung lesions, congenital diaphragmatic hernia, and sacrococcygeal teratoma. Semin Pediatr Surg 2003; 12:154-167.
85. Morrow RJ, Macphail S, Johnson JA, Ryan G, Farine D, Knox Ritchie JW. Midtrimester thoracoamniotic shunting for the treatment of fetal hydrops. Semin Pediatr Surg 2003; 12(3):182-189.
86. Wilson RD, Johnson MP. Prenatal ultrasound guided percutaneous shunts for obstructive uropathy and thoracic disease. Ultrasound Obstetr Gynecol 2003; 22(5):484-488.
87. Gallot D, Laurichesse H, Lemery D. Selective feticide in monochorionic twin pregnancies by ultrasound-guided umbilical cord occlusion. Ultrasound Obstetr Gynecol 2003; 22(4):409-419.
88. Tan TY, Sepulveda W. Acardiac twin: a systematic review of minimally invasive treatment modalities. Ultrasound Obstetr Gynecol 2003; 22(4):409-419.
89. Quintero RA. Twin-twin transfusion syndrome. Clin Perinatol 2003; 30:591-600.
90. Alkazaleh F, Barrea C, Hornberger LK, Seaward G, Greg R. Outcome and acute changes of the cardiovascular manifestations in the recipient twin after laser therapy for severe twin-to-twin transfusion syndrome (TTTS). J Soc Gynecol Invest 2002; 9:70A.
91. Kohl T, Sharland G, Allan LD, Gembruch U, Chaoui R, Lopes LM, Zielinsky P, Huhta J, Silverman NH. World experience of percutaneous ultrasound-guided balloon valvuloplasty in human fetuses with severe aortic valve obstruction. Am J Cardiol 2000; 85(10):1230-1233.
92. Tworetzky W, Marshall AC. Balloon valvuloplasty for congenital heart disease in the fetus. Clin Perinatol 2003; 30(3):541-550.